Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005.

Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH.

Circ Arrhythm Electrophysiol. 2008 Oct;1(4):240-9. doi: 10.1161/CIRCEP.108.777888.

2.

Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.

Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM.

JAMA. 2009 Apr 22;301(16):1661-70. doi: 10.1001/jama.2009.547.

3.

Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up.

Gould PA, Gula LJ, Champagne J, Healey JS, Cameron D, Simpson C, Thibault B, Pinter A, Tung S, Sterns L, Birnie D, Exner D, Parkash R, Skanes AC, Yee R, Klein GJ, Krahn AD.

Heart Rhythm. 2008 Dec;5(12):1675-81. doi: 10.1016/j.hrthm.2008.09.020. Epub 2008 Sep 23.

PMID:
19084804
4.

Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis JP, Tzou WS, Varosy PD, Kremers MS, Masoudi FA.

Circulation. 2014 Sep 2;130(10):845-53. doi: 10.1161/CIRCULATIONAHA.114.008653. Epub 2014 Aug 5.

5.

Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.

Hsu JC, Varosy PD, Parzynski CS, Chaudhry SI, Dewland TA, Curtis JP, Marcus GM.

Am Heart J. 2015 Jan;169(1):45-52.e3. doi: 10.1016/j.ahj.2014.10.006. Epub 2014 Oct 25.

PMID:
25497247
6.

Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.

Gadler F, Valzania C, Linde C.

Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21.

PMID:
25336667
7.

In-hospital complications associated with reoperations of implantable cardioverter defibrillators.

Steckman DA, Varosy PD, Parzynski CS, Masoudi FA, Curtis JP, Sauer WH, Nguyen DT.

Am J Cardiol. 2014 Aug 1;114(3):419-26. doi: 10.1016/j.amjcard.2014.05.010. Epub 2014 May 16.

PMID:
24927972
8.

A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement.

Heidenreich PA, Tsai V, Curtis J, Wang Y, Turakhia MP, Masoudi FA, Varosy PD, Goldstein MK.

Am Heart J. 2015 Aug;170(2):281-289.e2. doi: 10.1016/j.ahj.2014.12.013. Epub 2015 Jan 7.

PMID:
26299225
9.

Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death.

Bilchick KC, Stukenborg GJ, Kamath S, Cheng A.

J Am Coll Cardiol. 2012 Oct 23;60(17):1647-55. doi: 10.1016/j.jacc.2012.07.028. Epub 2012 Sep 26.

10.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

11.

Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction.

Pokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, Al-Khatib SM, Peterson ED, Wang TY.

JAMA. 2015 Jun 23-30;313(24):2433-40. doi: 10.1001/jama.2015.6409.

PMID:
26103027
12.

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.

Khazanie P, Hellkamp AS, Fonarow GC, Bhatt DL, Masoudi FA, Anstrom KJ, Heidenreich PA, Yancy CW, Curtis LH, Hernandez AF, Peterson ED, Al-Khatib SM.

J Am Heart Assoc. 2015 Aug 6;4(8):e002061. doi: 10.1161/JAHA.115.002061.

13.

Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.

Roth GA, Poole JE, Zaha R, Zhou W, Skinner J, Morden NE.

J Am Coll Cardiol. 2016 Mar 8;67(9):1062-9. doi: 10.1016/j.jacc.2015.12.046.

14.

Physician procedure volume and complications of cardioverter-defibrillator implantation.

Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA.

Circulation. 2012 Jan 3;125(1):57-64. doi: 10.1161/CIRCULATIONAHA.111.046995. Epub 2011 Nov 17.

15.

Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.

Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD.

J Am Coll Cardiol. 2011 Aug 30;58(10):1007-13. doi: 10.1016/j.jacc.2011.04.039.

16.

Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).

Russo AM, Daugherty SL, Masoudi FA, Wang Y, Curtis J, Lampert R.

Am Heart J. 2015 Aug;170(2):330-8. doi: 10.1016/j.ahj.2015.02.025. Epub 2015 Apr 23.

17.

Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.

Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ.

Circulation. 2014 Sep 23;130(13):1037-43. doi: 10.1161/CIRCULATIONAHA.114.009081. Epub 2014 Jul 31.

18.

The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries.

Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE.

J Am Coll Cardiol. 2005 Oct 18;46(8):1536-40. Epub 2005 Sep 23. Erratum in: J Am Coll Cardiol. 2005 Nov 15;46(10):1964.

19.

Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.

Biton Y, Moss AJ, Kutyifa V, Mathias A, Sherazi S, Zareba W, McNitt S, Polonsky B, Barsheshet A, Brown MW, Goldenberg I.

Circ Heart Fail. 2015 Sep;8(5):921-6. doi: 10.1161/CIRCHEARTFAILURE.115.002208. Epub 2015 Jul 15.

20.

Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.

Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM.

Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):582-90. doi: 10.1161/CIRCOUTCOMES.113.000299. Epub 2013 Sep 3.

Supplemental Content

Support Center